Transcriptional regulation of the genes involved in lipoprotein transport: The role of proximal promoters and long-range regulatory elements and factors in apolipoprotein gene regulation

Hypertension

Volumn 27, Issue 4, 1996, Pages 980-1008

  Kardassis, Dimitris ^a,b   Laccotripe, Maria ^a   Talianidis, Iannis ^b   Zannis, Vassilis ^a,b  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CRETE   (Greece)

Author keywords

apolipoproteins; eukaryotic genes; gene expression regulation; genes, regulator; transcription factors

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN A4; APOLIPOPROTEIN B; APOLIPOPROTEIN C1; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; COMPLEMENTARY DNA;

ATHEROSCLEROSIS; BINDING SITE; CONFERENCE PAPER; DNA PROTEIN COMPLEX; ENHANCER REGION; GENE CLUSTER; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HYPERLIPIDEMIA; LIPOPROTEIN METABOLISM; PRIORITY JOURNAL; PROMOTER REGION; SILENCER GENE; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION;

EID: 0029975844     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.27.4.980     Document Type: Conference Paper

References (116)

1. Hernandez N. TBP: a universal eukaryotic transcription factor? Genes Dev. 1993;7:1291-1308.
2. Klug A. Transcription: opening the gateway. Nature. 1993;365: 486-487.
3. Tjian R, Maniatis T. Transcriptional activation: complex puzzle with few easy pieces. Cell. 1994;77:5-8.
4. Weis L, Reinberg D. Transcription by RNA polymerase II: initiator directed formation of transcription competent complexes. FASEB J. 1992;6:3300-3309.
5. Buratowski S. The basics of basal transcription by RNA polymerase II. Cell. 1994;77:1-3.
6. Ha I, Roberts S, Maldonado E, Sun X, Kim LU, Green M, Reinberg D. Multiple functional domains of human transcription factor IIB: distinct interactions with two general transcription factors and RNA polymerase II. Genes Dev. 1993;7:1021-1032.
7. Conaway RC, Conaway JW. General initiation factors for RNA polymerase II. Annu Rev Biochem. 1993;62:161-190.
8. Flores O, Lu H, Reinberg D. Factors involved in specific transcription by mammalian RNA polymerase II: identification and characterization of factor IIH. J Biol Chem. 1992;267:2786-2793.
9. Flores O, Lu H, Killeen M, Greenblatt J, Burton ZF, Reinberg D. The small subunit of transcription factor IIF recruits RNA polymerase II into the pre-initiation complex. Proc Natl Acad Sci USA. 1991;88:9999-10003.
10. Killeen M, Coulombe B, Greenblatt J. Recombinant TBP, transcription factor IIB, and RAP30 are sufficient for promoter recognition by mammalian RNA polymerase II. J Biol Chem. 1992;267:9463-9466.
11. Tyree CM, George CP, Lira-DeVito LM, Wampler SL, Dahmus ME, Zawel L, Kadonaga JT. Identification of a minimal set of proteins that is sufficient for accurate initiation of transcription by RNA polymerase II. Genes Dev. 1993;7:1254-1265.
12. Sawadogo M, Roeder RG. Energy requirement for specific transcription initiation by the human RNA polymerase II system. J Biol Chem. 1984;259:5321-5326.
13. Stringer KF, Ingles CJ, Greenblatt J. Direct and selective binding of an acidic transcriptional activation domain to the TATA-box factor TFIID. Nature. 1990;345:783-786.
14. Brinster RI, Chen HY, Trumbauer ME, Yagle MK, Palmiter RD. Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs. Proc Natl Acad Sci USA. 1985;82: 4438-4442.
15. Hogun B. Manipulating the Mouse Embryo. A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Press: 1986.
16. Treisman R. Identification of a protein binding site that mediates transcriptional response of the c-fos gene to serum factors. Cell. 1986;46:567-574.
17. Becker PB, Ruppert S, Schutz G. Genomic footprinting reveals cell type-specific DNA binding of ubiquitous factors. Cell. 1987;51:436-443.
18. Cartwright IL, Kelly SE. Probing the nature of chromosomal DNA-protein contacts by in vivo footprinting. Biotechniques. 1991;11:188-203.
19. Fried M, Crothers DM, Equilibria and kinetics of lac repressor-operator interactions by PAGE. Nucleic Acids Res. 1981;9: 6505-6525.
20. Truss M, Chalepakis G, Beato M. Contacts between steroid hormone receptors and thymines in DNA: an interference method. Proc Natl Acad Sci USA. 1990;87:7180-7184.
21. Kadonaga JT, Tjian R. Affinity purification of sequence-specific DNA binding proteins. Proc Natl Acad Sci USA. 1986;83: 5889-5893.
22. Kadonaga JT, Carner KR, Masiarz SR, Tjian R. Isolation of cDNA encoding transcription factor SP1 and functional analysis of the DNA binding domain. Cell. 1987;51:1079-1090.
23. Tronche F, Bach I, Chourad T, Wattine BD, Pontoglio M, Ringeisen F, Sourdive D, Thepot D, Yaniv M. Hepatic nuclear factor 1 (HNF1) and liver gene expression. In: Tronche F, Yaniv M, eds. Liver Gene Expression. Austin, Tex: RG Landes Co; 1994:156-181.
24. Evans RM. The steroid and thyroid hormone receptor super-family. Science. 1988;240:889-895.
25. Castelli WP, Doyle JT, Gordon T, Hames CG, Hjortland MC Hulley SB, Kagan A, Zukel WJ. HDL cholesterol and other lipids in coronary artery disease: the cooperative lipoprotein phenotype study. Circulation. 1977;55:767-772.
26. Warden CH, Hedrick CC, Qiao JH, Castellani LW, Lusis AJ. Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. Science. 1993;261:469-472.
27. Ito Y, Azrolan N, O'Connel A, Walsh A, Breslow JL. Hypertriglyceridemia as a result of apoCIII gene expression in transgenic mice. Science. 1990;249:790-793.
28. Shimano H, Yamada N, Katsuki M, Shimada M, Gotoda T, Harada K, Murase T, Fukazawa C, Takaku F, Yazaki Y. Overexpression of apolipoprotein E in transgenic mice: marked reduction in plasma lipoprotein except high density lipoprotein and resistance against diet-induced hypercholesterolemia. Proc Natl Acad Sci USA. 1992;89:1750-1754.
29. Zannis VI, Kardassis D, Cardot P, Hadzopoulou-Cladaras M, Zanni EE, Cladaras C. Molecular biology of the human apolipoprotein genes: gene regulation and structure/function relationship. Curr Opin Lipidol. 1992;3:96-113.
30. Papazafiri P, Ogami K, Ramji DP, Nicosia A, Monaci P, Cladaras C, Zannis VI. Promoter elements and factors involved in hepatic transcription of the human apoA-I gene: positive and negative regulators bind to overlapping sites. J Biol Chem. 1991;266: 5790-5797.
31. Sladek FM, Zhong W, Lai E, Darnell JE Jr. Liver enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev 1990;4:2353-2365.
32. Frain M, Swart G, Monaci P, Nicosia A, Stampfli S, Franck R, Cortese R. The liver-specific transcription factor LF-B1 contains a highly diverged homeobox DNA binding domain. Cell. 1989;59: 145-157.
33. Costa RH, Grayson DR, Darnell JE Jr. Multiple hepatocyte-enriched nuclear factors function in the regulation of transthyretin and α1-antitrypsin genes. Mol Cell Biol. 1989;9:1415-1425.
34. Landschulz WH, Johnson PF, Adashi E, Graves BJ, McKnight SL. Isolation of a recombinant copy of the gene encoding C/EBP. Genes Dev. 1988;2:786-800.
35. Jones KA, Kadonaga JT, Rosenfeld PJ, Kelly TJ, Tjian R. A cellular DNA binding protein that activates eukaryotic transcription and DNA replication. Cell. 1987;48:79-89.
36. Hooft van Huijsduijnen R, Li XY, Black D, Matthes H, Benoist C, Mathis D. Co-evolution from yeast to mouse: cDNA cloning of the two NFY (CP-l/CBF) subunits. EMBO J. 1990;9:3119-3127.
37. Briggs MR, Kadonaga JT, Bell SP, Tjian R. Purification and biochemical characterization of the promoter-specific transcription factor SP-1. Science. 1986;234:47-52.
38. Lamarco KL, Thompson CC, Byers BP, Walton EM, McKnight S. Identification of Ets- and notch-related subunits in GA binding protein. Science. 1991;253:789-792.
39. Karathanasis SK. Apolipoprotein multigene family: tandem organization of human apolipoprotein AI, CIII, and AIV genes. Proc Natl Acad Sci USA. 1985;82:6374-6378.
40. Ogami K, Hadzopoulou-Cladaras M, Cladaras C, Zannis VI. Promoter elements and factors required for hepatic and intestinal transcription of the human apoCIII gene. J Biol Chem. 1990;265: 9808-9815.
41. Talianidis I, Tambakaki A, Toursounova J, Zannis VI. Complex interactions between SP1 bound to multiple distal regulatory sites and HNF-4 bound to the proximal promoter lead to transcriptional activation of liver-specific human apoCIII gene. Bio-chemistry. 1995;34:10298-10309.
42. Lauer SJ, Simonet WS, Bucay N, de Suva HV, Taylor JM. Tissue-specific expression of the human apolipoprotein A-IV gene in transgenic mice. Circulation. 1991;84:1390. Abstract.
43. Ktistaki E, Lacorte J-M, Katrakili N, Zannis VI, Talianidis I. Transcriptional regulation of the apolipoprotein A-IV gene involves synergism between a proximal orphan receptor response element and a distant enhancer located in the upstream promoter region of the apolipoprotein C-III gene. Nucleic Acids Res. 1994;22:4689-4696.
44. Kardassis D, Tzameli E, Talianidis I, Zannis VI. The apoCIII enhancer activates the promoter of the tandemly linked apoA-I gene in HepG2 and CaCo-2 cells by distinct mechanisms. Circulation. 1995;92:290. Abstract.
45. Walsh A, Azrolan N, Wang K, Marcigliano A, O'Connel A, Breslow JL. Intestinal expression of the human apoA-I gene is controlled by a DNA region 3′ to the gene in the promoter of the adjacent convergently transcribed apoCIII gene, J. Lipid Res. 1993;34:617-623.
46. Bisaha JG, Simons TC, Gordon JL, Breslow JL. Characterization of an enhancer element in the human apolipoprotein C-III gene that regulates human apolipoprotein A-I gene expression in the intestinal epithelium. J Biol Chem. 1995;270:19979-19988.
47. Ginsburg GS, Ozer J, Karathanasis SK. Intestinal apolipoprotein AI gene transcription is regulated by multiple distinct DNA elements and is synergistically activated by the orphan nuclear receptor, hepatocyte nuclear factor 4. J. Clin Invest. 1995;96:528-538.
48. Walsh A, Ito Y, Breslow JL. High levels of the human apolipoprotein A-I in transgenic mice result in increased plasma levels of small high density lipoprotein (HDL) particles comparable to human HDL3. J Biol Chem. 1989;264:6488-6494.
49. Chambaz J, Cardot P, Pastier D, Zannis VI, Cladaras C. Promoter elements and factors required for hepatic transcription of the human apoA-II gene. J Biol Chem. 1991;266:11676-11685.
50. Shelley CS, Baralle FE. Dual tissue-specific expression of apoA-II is directed by an upstream enhancer. Nucleic Acids Res. 1987;15: 3801-3821.
51. Hadzopoulou-Cladaras M, Cardot P. Identification of a cis-acting negative DNA element which modulates human hepatic triglyceride lipase gene expression. Biochemistry. 1993;32:9657-9667.
52. Brooks AR, Blackhart BD, Haubold K, Levy-Wilson B. Characterization of tissue specific enhancer elements in the second intron of the human apolipoprotein gene. J Biol Chem. 1991;266: 7848-7859.
53. Levy-Wilson B, Paulweber B, Nagy BP, Ludwig EH, Brooks AR. Nuclear-hypersensitive sites define a region with enhancer activity in the third intron of the human apolipoprotein B gene. J Biol Chem. 1992;267:18735-18743.
54. Brooks AR, Nagy BP, Taylor S, Simonet WS, Taylor JM, Levy-Wilson B. Sequences containing the second-intron enhancer are essential for transcription of the human apolipoprotein B gene in the livers of transgenic mice. Mol Cell Biol. 1994;14:2243-2256.
55. Dang Q, Walker D, Taylor S, Allan C, Chin P, Fan J, Taylor JW. Structure of the hepatic control region of the human apolipoprotein E/C-I gene locus. J Biol Chem. 1995;270:22577-22585.
56. Allan C, Walker D, Taylor JM. Evolutionary duplication of a hepatic control region in the human apolipoprotein E gene locus. J Biol Chem. 1995;270:26278-26281.
57. Lucero MA, Sanchez D, Ochoa AR, Brunel F, Cohen GN, Baralle FE, Zakin MM. Interaction of DNA-binding proteins with the tissue-specific human apolipoprotein A-II enhancer. Nucleic Acids Res. 1989;17:2283-2300.
58. Ogami K, Kardassis D, Cladaras C, Zannis VI. Purification and characterization of a heat stable nuclear factor CIIIB1 involved in the regulation of the human apoCIII gene. J Biol Chem. 1991;266: 9640-9646.
59. Cardot P, Chambaz J, Cladaras C, Zannis VI. Regulation of the human apoA-II gene by the synergistic action of factors binding to the proximal and distal regulatory elements. J Biol Chem. 1991;266:24460-24470.
60. Cardot P, Chambaz J, Kardassis D, Cladaras C, Zannis VI. Factors participating in the liver-specific expression of the human apolipoprotein A-II gene and their significance for transcription. Biochemistry. 1993;32:9080-9093.
61. Cardot P, Pastier D, Lacorte JM, Mangeney M, Zannis VI, Chambaz J. Purification and characterization of nuclear factors binding to the negative regulatory element D of human apolipoprotein A-II promoter: a negative regulatory effect is reversed by GABP, an Ets-related protein Biochemistry. 1994;33:12139-12148.
62. Glass CK. Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers. Endocr Rev. 1994;15:391-407.
63. Giguere V. Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signaling. Endocr Rev: 1994;15:61-79.
64. Mangelsdorf DJ, Umesono K, Evans RM. The retinoid receptors. In: The Retinoids: Biology, Chemistry and Medicine. 2nd ed. New York, NY: Raven Press; 1994;8:319-349.
65. Miyajima N, Kadowaki Y, Fukushige S, Shimizu S, Semba K, Yamanashi Y, Matsubara K, Toyosbima K, Yamamoto T. Identification of two novel members of erbA superfamily by molecular cloning: the gene products of the two are highly related to each other. Nucleic Acids Res. 1988;16:11057-11074.
66. Wang LH, Tsai SV, Cook RG, Beattie WG, Tsai MJ, O'Malley BW. COUP transcription factor is a member of the steroid receptor superfamily. Nature. 1989;340:163-166.
67. Ladias JA, Karathanasis SK. Regulation of the apolipoprotein A-I gene by ARP-1, a novel member of the steroid receptor super-family. Science. 1991;251:561-565.
68. Ladias JAA, Hadzopoulou-Cladaras M, Kardassis D, Cardot P, Cheng J, Zannis VI, Cladaras C. Transcriptional regulation of human apolipoprotein genes ApoB, ApoCIII, and ApoAII by members of the steroid hormone receptor superfamily HNF4, ARP-1, EAR-2, and EAR-3. J Biol Chem. 1992;267:15849-15860.
69. Vu-Duc N, Schoonjana K, Kosykh V, Dallongeville J, Fruchart J-C, Staels B, Auwerx J. Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor. J Clin Invest. 1995;96:741-750.
70. Wang X, Briggs MR, Hua X, Yokoyama C, Golstein JL, Brown MS. Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter, II: purification and characterization. J Biol Chem. 1993;268:14497-14504.
71. Pissios P, Kan HY, Nagaoga S, Chambaz J, Zannis VI. SREBP-1 binds to multiple sites of the apoA-II promoter and downregulates the apoA-II gene transcription. Circulation. 1995;92:292. Abstract.
72. Bossu J-P, Chartier FL, Vu-Dac N, Fruchart J-C, Laine B. Transcription of the human apolipoprotein A-II is down-regulated by the first intron of its gene. Biochem Biophys Res Commun. 1994;202:822-829.
73. Levy-Wilson B, Fortier C. The limits of the DNase I-sensitive domain of the human apolipoprotein B gene coincide with the location of chromosomal anchorage loops and define the 5′ and 3′ boundaries of the gene. J Biol Chem. 1989;264:21196-21204.
74. Kardassis D, Hadzopoulou-Cladaras M, Ramji DP, Cortese R, Zannis VI, Cladaras C. Characterization of the promoter elements required for hepatic and intestinal transcription of the human apoB gene: definition of the DNA-binding site of a tissue-specific transcriptional factor. Mol Cell Biol. 1990;10:2653-2659.
75. Kardassis D, Zannis VI, Cladaras C, Organization of the regulatory elements and nuclear activities participating in the transcription of the human apolipoprotein B gene. J Biol Chem. 1992;267:2622-2632.
76. Paulweber B, Sandhofer F, Levy-Wilson B. The mechanism by which the human apolipoprotein B gene reducer operates involves blocking of transcriptional activation by hepatocyte nuclear factor 3. Mol Cell Biol. 1993;13:1534-1546.
77. Metzger S, Hallaas JL, Breslow JL, Sladek FM. Orphan receptor HNF4 and bZIP protein C/EBP bind to overlapping regions of the apolipoprotein B gene promoter and synergistically activate transcription. J Biol Chem. 1993;268:16831-16838.
78. Kardassis D, Zannis VI, Cladaras C. Purification and characterization of the nuclear factor BA1: a transcriptional activator of the human apoB gene. J Biol Chem. 1990;265:21733-21740.
79. Brooks AR, Levy-Wilson B. Hepatocyte nuclear factor 1 and C/EBP are essential for the activity of the human apolipoprotein B gene second-intron enhancer. Mol Cell Biol. 1992;12:1134-1148.
80. Widom RL, Ladias JAA, Kouidou S, Karathanasis SK. Synergistic interactions between transcription factors control expression of the apolipoprotein A-I gene in liver cells. Mol Cell Biol. 1991;11: 677-687.
81. Rottman JN, Widom RL, Nadal-Ginard B, Mahdavi V, Karathanasis SK, A retinoic acid-responsive element in the apolipoprotein AI gene distinguishes between two different retinoic acid response pathways. Mol Cell Biol. 1991;11:3814-3820.
82. Tzameli I, Zannis VI. Binding specificity and modulation of the apoA-1 promoter activity by homo- and heterodimers of nuclear receptors. J Biol Chem. In press.
83. Tzameli I. Transcriptional Regulation of the Human ApoA-I Gene: The Role of Hormone Nuclear Receptors. Boston, Mass: Boston University School of Medicine: 1995. Dissertation.
84. Vu-Dac N, Schoonjans K, Laine B, Fruchart J-C, Auwerx J, Staels B. Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element. J Biol Chem. 1994;269:31012-31018.
85. Ge R, Rhee M, Malik S, Karathanasis SK. Transcriptional repression of apolipoprotein AI gene expression by orphan receptor ARP-1. J Biol Chem. 1994;269:13185-13192.
86. Kilbourne EJ, Widom R, Harnish DC, Malik S, Karathanasis SK. Involvement of early growth response factor Egr-1 in apolipoprotein AI gene transcription. J Biol Chem. 1995;270:7004-7010.
87. Harnish DC, Malik S, Karathanasis SK. Activation of apolipoprotein AI gene transcription by the liver-enriched factor HNF-3. J Biol Chem. 1994;269:28220-28226.
88. Mietus-Snyder MM, Sladek FM, Ginsburg GS, Kuo CF, Ladias JAA, Darnell JE Jr, Karathanasis SK. Antagonism between apolipoprotein A-I regulatory protein l, EAR-3/COUP-TF, and HNF-4 modulates apoCIII gene expression in liver and intestinal cells. Mol Cell Biol. 1992;12:1708-1718.
89. Hertz R, Bishara-Snieban J, Bar-Tana J. Mode of action of peroxisome proliferators as hypolipidemic drugs. J Biol Chem. 1995;270:13470-13475.
90. Lavrentiadou S, Hatzopoulou-Cladaras M, Ladias J, Cladaras C, Zannis V. Modulation of the apoCIII promoter activity by heterodimers of ligand dependent nuclear receptors RXRα-RARα, RXRα-T3Rβ and RXRα-PPARα. Circulation. 1995;92:291. Abstract.
91. Cladaras C, Ogami K, Kardassis D, Hadzopoulou-Cladaras M, Zannis VI. Recognition of proximal apoCII promoter by NFY type, C/EBP, and a family of heat stable activities. Circulation. 1991;84:109. Abstract.
92. Gruber PJ, Torres-Rosado A, Wolak ML, Leff T. ApoCIII gene transcription is regulated by a cytokine inducible NF-κB element. Nucleic Acids Res. 1994;22:2417-2422.
93. O'Brien RM, Lucas PC, Yamasaki T, Bonovich MT, Forest CD, Granner DK. Insulin and phorbol esters act through the same DNA element to inhibit phosphoenolpyruvate carboxykinase gene transcription. Biochem Soc Trans. 1992;20:686-690.
94. Chen M, Breslow JL, Li W, Leff T. Transcriptional regulation of the apoC-III gene by insulin in diabetic mice: correlation with changes in plasma triglyceride levels. J Lipid Res. 1994;35: 1918-1924.
95. Karathanasis SK, Yunis I, Zannis VI. Structure, evolution and tissue-specific synthesis of human apolipoprotein A-IV. Bio-chemistry. 1986;25:3962-3970.
96. Elshourbagy NA, Walker DW, Paik YK, Boguski MS, Freeman M, Gordon JI, Taylor JM. Structure and expression of the human apolipoprotein A-IV gene. J Biol Chem. 1987;262:7973-7981.
97. Ochoa A, Bovard-Houppermans S, Zakin MM. Human apoA-IV gene expression is modulated by members of the nuclear hormone receptor superfamily. Biochim Biophys Acta. 1993;1210:41-47.
98. Omori K, Vergnes L, Zakin MM, Ochoa A. The apolipoprotein AICIII-AIV gene cluster: sequence of the apoCIII-apoAIV intergenic region. Gene. 1995;159:231-234.
99. Giese K, Cox J, Grosschedl R. The HMG domain of lymphoid enhancer factor 1 bends DNA and facilitates assembly of functional nucleoprotein structures. Cell. 1992;69:185-195.
100. Giese K, Grosschedl R. LEF-1 contains an activation domain that stimulates transcription only in a specific context of factor-binding sites. EMBO J. 1993;12:4667-4676.
101. Carlsson P, Waterman ML, Jones KA. The hLEF/TCF-1α HMG protein contains a context-dependent transcriptional activation domain that induces the TCRα enhancer in T cells. Genes Dev. 1993;7:2418-2430.
102. Thanos D, Maniatis T. The high mobility group protein HMG I(Y) is required for NF-κB-dependent virus induction of the human IFN-β gene. Cell. 1992;71:777-789.
103. Du W, Thanos D, Maniatis T. Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elements. Cell. 1993;74:887-898.
104. de Suva HV, Lauer SJ, Wang J, Simonet WS, Weisgraber KH, Mahley RW, Taylor JM. Overexpression of human apolipnprotein C-III in transgenic mice results in an accumulation of apolipoprotein B48 remnants that is corrected by excess apolipoprotein E. J Biol Chem. 1994;269:2324-2335.
105. Lusts AJ, Heinzmann C, Sparkes RS, Scott J, Knott TJ, Geller R, Sparkes MC, Mohandas T. Regional mapping of human chromosome 19: organization of genes for plasma lipid transport (apoC1-C2 and -E and LDLr) and the genes C3, PEPD and GPI. Proc Natl Acad Sci USA. 1986;83:3929-3933.
106. Allan CM, Walker D, Segrest JP, Taylor JM. Identification and characterization of a new human gene (ApoC4) in the apolipoprotein E, C-I, and C-II gene locus. Genomics. 1995;28:291-300.
107. Smith JD, Melian A, Leff T, Breslow JL. Expression of the human apolipoprotein E gene is regulated by multiple positive and negative elements. J Biol Chem. 1988;263:8300-8308.
108. Chang DJ, Paik YK, Leren TP, Walker DW, Howlett GJ, Taylor JM. Characterization of a human apolipoprotein E gene enhancer element and its associated protein factors. J Biol Chem. 1990;265: 9496-9504.
109. Taylor JM, Simonet WS, Bucay N, Lauer SJ, dc Suva HV. Expression of the human apolipoprotein E/apolipoprotein C-I gene locus in transgenic mice. Curr Opin Lipidol. 1991;2:73-80.
110. Simonet WS, Bucay N, Pitas RE, Lauer SJ, Taylor JM. Multiple tissue-specific elements control the apolipoprotein E/C-I gene locus in transgenic mice. J Biol Chem. 1991;266:8651-8654.
111. Simonet WS, Bucay N, Lauer SJ, Taylor JM. A far-downstream hepatocyte-specific control region directs expression of the linked human apolipoprotein E and CI genes in transgenic mice. J Biol Chem. 1993;268:8221-8229.
112. Shachter NS, Zhu Y, Walsh A, Breslow JL, Smith JD. Localization of a liver specific enhancer in the apolipoprotein E/C-I/C-II gene locus. J Lipid Res. 1993;34:1699-1707.
113. Brunei F, Alzari PM, Ferrara P, Zakin MM. Cloning and sequencing of PYBP, a pyrimidine-rich specific single strand DNA binding protein. Nucleic Acids Res. 1991;19:5237-5245.
114. Churchill ME, Jones DNM, Glasser T, Hefner H, Searles MA, Travers AA. HMG-D is an architecture-specific protein that preferentially binds to DNA containing the dinucleotide TG. EMBO J. 1995;14:1264-1275.
115. Ochoa A, Brunel F, Mendelson D, Cohen GN, Zakin MM. Different liver nuclear proteins bind to similar DNA sequences in the 5' flanking regions of three hepatic genes. Nucleic Acids Res. 1989;17:119-133.
116. Wilson DB, Dorfman DM, Orkin SH. A nonerythroid GATA-binding protein is required for function of the human pre-procndothelin-1 promoter in endothelia) cells. Mol Cell Biol. 1990;10:4854-4862.